CAPRICOR THERAP. DL-001 (4LN2 F) stock market data APIs

€13.54 0.5(3.8%)
as of February 11, 2025

CAPRICOR THERAP. DL-001 Financial Data Overview

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.

Prev. Close 12.7
Open 13.54
High 12.98
Low 12.69
52 wk Range 3.265-20.45
Market Cap 616 M
Shares Outstanding 45 470 K
Revenue 23 228 K
EPS -0.21
Beta 4.016

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get CAPRICOR THERAP. DL-001 data using free add-ons & libraries


Get CAPRICOR THERAP. DL-001 Fundamental Data

CAPRICOR THERAP. DL-001 Fundamental data includes:

  • Net Revenue: 23 228 K
  • EBITDA: -34 769 880
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get CAPRICOR THERAP. DL-001 Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2021-06-30
  • EPS/Forecast: -0.23
GET THE PACKAGE

Get CAPRICOR THERAP. DL-001 End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat